An Evaluation of Hepatitis A Seroprevalence and Vaccination Status in Patients with HIV/AIDS: Data from A 20-year Period-Reference-Cited by-同舟云学术

An Evaluation of Hepatitis A Seroprevalence and Vaccination Status in Patients with HIV/AIDS: Data from A 20-year Period

Published:2023-05-31 Issue:2 Volume:24 Page:144-148
ISSN:2619-9793
Container-title:Istanbul Medical Journal
language:
Short-container-title:Istanbul Med J

Author:

Zerdali Esra^ORCID,Karanalbant Hatice Kübra^ORCID,Kültür Melike Nur^ORCID,Yılmaz Nakir İnci^ORCID,Pehlivanoğlu Filiz^ORCID

Publisher

Galenos Yayinevi

Reference19 articles.

1. 1. World Health Organization. Fact Sheets: Hepatitis A (İnternet). Geneva: WHO (erişim 9 Aralık 2022) https://www.who.int/news-room/fact-sheets/detail/hepatitis-a

2. 2. Bulaşıcı Hastalıklar Dairesi Başkanlığı ve Aşı İle Önlenebilir Hastalıklar Dairesi Başkanlığı. Türkiye Viral Hepatit Önleme ve Kontrol Programı 2018-2023 (İnternet). Ankara: Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü (erişim 9 Aralık 2022). https://hsgm.saglik.gov.tr/depo/birimler/Bulasici-hastaliklar-db/duyurular/Turkiye_Viral_Hepatit_Onleme_ve_Kontrol_Programi/Turkiye_Viral_Hepatit_Onleme_ve_Kontrol_Programi_TR.pdf.

3. 3. Nelson NP, Weng MK, Hofmeister MG, Moore KL, Doshani M, Kamili S, et al. Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020. MMWR Recomm Rep 2020; 69: 1-38. Erratum in: MMWR Morb Mortal Wkly Rep 2021; 70: 294.

4. 4. McGowan JP, Fine SM, Vail R, Merrick ST, Radix A, Hoffmann CJ, Gonzalez CJ. New York State Department of Health AIDS Institute Guideline: Prevention and Management Of HAV In Adults With HIV. Reviewed and updated: Hector I. Ojeda-Martinez; May 2021 (erişim 9 Aralık 2022). https://www.hivguidelines.org/hiv-care/hav-hiv-coinfection/

5. 5. Mıstık R. Türkiye'de hepatit A virüs enfeksiyonunun epidemiyolojisi. In: Tabak F, Güner R, eds. Viral Hepatit 2018. İstanbul: İstanbul Tıp Kitabevleri; 2018.s.1-12.